Tumor tissue CA125 in ovarian carcinoma patients with normal serum levels

International Journal of Gynecological Cancer

Volumn 7, Issue 4, 1997, Pages 304-306

  Menczer, J ^a   Zakut, H ^a   Schejter, E ^a   Ginath, S ^a   Tell, L ^a   Zajdel, L ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Ovarian carcinoma; Serum CA125; Tissue CA125

Indexed keywords

CA 125 ANTIGEN; PARAFFIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SECOND LOOK SURGERY; TISSUE DISTRIBUTION; TISSUE LEVEL; TISSUE SECTION;

EID: 0030693376     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00459.x     Document Type: Article

References (15)

1. Bast RC, Klung TL, John ES, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Eng J Med 1983; 309: 883-7.
2. Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell type. Am J Clin Pathol 1983; 79: 98-104.
3. Bast RC, Knapp RC. Immunologic approach to the management of ovarian carcinoma. Semin Oncol 1984; 11: 264-74.
4. Dietel M, Arps H, Klapdor R, Muller-Hagen S, Sieck M, Hofman L. Antigen detection by the monoclonal antibodies CA1909 and CA125 in normal and tumor tissue and patients' sera. J Cancer Res Clin Oncol 1986; 111: 257-65.
5. Breitnecker G, Neunteufel W, Bieglmayer C, Kolbl H, Scheider K. Comparison between tissue and serum content of CA125, CA19-9 and carcinoembryonic antigen in ovarian tumours. Int J Gynecol Pathol 1989; 8: 97-102.
6. Leake J, Woolas RP, Daniel J, Oram DM, Brown C. Immunocytochemical and serological expression of CA125: A clinicopathological study of 40 malignant ovarian epithelial tumours. Histopathology 1994; 24: 57-64.
7. Motoyama T, Watanabe H, Takeuchi S, Watanabe T, Gotom S, Okazaki E. Cancer antigen 125, carcinoembryonic antigen and carbohydrate determinant 19-9 in ovarian tumors. Cancer 1990; 66: 2628-35.
8. Nouwen EJ, Hendrix PG, Dauwe S, Eerdekens MW, DeBroe ME. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol 1987; 126: 230-42.
9. Ghazizadeh M, Sasaki Y, Oguro T, Aihara K, Tenjin H, Araki T. Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours. Histopathology 1990; 17: 123-8.
10. Fleuren GJ, Nap M, Aalders JG, Trimbos JB, DeBruijn HWA. Explanation of the limited correlation between tumour CA125 content and serum CA125 antigen levels in patients with ovarian carcinoma. Cancer 1987; 60: 2437-42.
11. Menczer J, Ben-Baruch G, Moran O, Lipitz S. Cyst fluid CA125 levels in ovarian epithelial neoplasms. Obstet Gynecol 1993; 81: 25-8.
12. Ferguson AM, Fox H. A study of the CA antigen in epithelial tumors of the ovary. J Clin Pathol 1984; 37: 6-9.
13. Koelma IA, Nap M, Rodenburg CJ, Fleuren GJ. The value of tumor marker CA-125 in surgical pathology. Histopathology 1987; 11: 287-94.
14. Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Preoperative serum CA125 levels in borderline tumors of the ovary. Gynecol Oncol 1992; 46: 226-9.
15. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognised by the monoclonal antibody OC 125. Int J Gynecol Pathol 1983; 2: 275-85.